Items where authors include "Bauer, S"
Up a levelArticle
Pantaleo, MA, Heinrich, MC, Italiano, A et al. (11 more authors) (2022) A multicenter, dose-finding, phase 1b study of imatinib in combination with alpelisib as third-line treatment in patients with advanced gastrointestinal stromal tumor. BMC Cancer, 22 (1). 511. 511-. ISSN 1471-2407
Farmer, AD, Strzelczyk, A, Finisguerra, A et al. (78 more authors) (2021) International Consensus Based Review and Recommendations for Minimum Reporting Standards in Research on Transcutaneous Vagus Nerve Stimulation (Version 2020). Frontiers in Human Neuroscience, 14. 568051. ISSN 1662-5161
Farmer, AD, Strzelczyk, A, Finisguerra, A et al. (78 more authors) (2021) International consensus based review and recommendations for minimum reporting standards in research on transcutaneous vagus nerve stimulation (version 2020). Frontiers in Human Neuroscience, 14. 568051.
Thornhill, G, Collins, W, Olivié, D et al. (23 more authors) (2021) Climate-driven chemistry and aerosol feedbacks in CMIP6 Earth system models. Atmospheric Chemistry and Physics, 21 (2). pp. 1105-1126. ISSN 1680-7316
Schöffski, P, Wozniak, A, Stacchiotti, S et al. (20 more authors) (2019) Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 ‘CREATE’. Annals of Oncology, 30 (2). p. 344. ISSN 0923-7534
Schöffski, P, Wozniak, A, Kasper, B et al. (23 more authors) (2018) Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3: European Organization for Research and Treatment of Cancer (EORTC) phase II trial 90101 ‘CREATE’. Annals of Oncology, 29 (3). pp. 758-765. ISSN 0923-7534
Schöffski, P, Wozniak, A, Stacchiotti, S et al. (20 more authors) (2017) Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 ‘CREATE’. Annals of Oncology, 28 (12). pp. 3000-3008. ISSN 0923-7534